Emotions Trump Logic Every Time<br />By Rev Shark<br />RealMoney.com Contributor<br />5/7/2008 8:42 AM EDT <br /><br /><br />Logic, like whiskey, loses its beneficial effect when taken in too large quantities. <br />-- Lord Dunsany<br /><br />What ultimately makes the market so difficult, and so potentially profitable, is that it isn't a logical beast. When we try to be highly analytical in determining how things will unfold, we almost always tend to be incorrect because we fail to account for the emotions of market players. <br /><br />Since the market is trying to price in future events, emotions and psychology have more impact than logic. While we like to think we can logically determine the future, human nature constantly gets in the way. <br /><br />I bring up the illogic of the markets this morning because many folks seemed quite puzzled by the strong price action yesterday even though oil prices were hitting record highs and some big losses were taken again in the financial sector. The way the market is acting at this point is as if it is pricing in steady economic improvement from here. <br /><br />The great difficulty for a thinking investor at this point is trying to reconcile the optimistic emotions about the market that obviously exist with the illogic that a recovery will come easily given record high oil prices, a slow economy and signs of increased inflation. <br /><br />We have to wrestle with the degree to which we respect the emotion of the market even though it differs from our logic. It is very easy to get into major trouble when you hold on to a logical position that differs from the emotions that are prevailing in the market. It doesn't much matter how compelling your thought process might be if the emotions of the market are going in the other direction. <br /><br />After the action yesterday, I find that my logic of where the market is headed is becoming further separated from the emotions that are dominating. I see a host of reasons why the market should pull back at this point, but it doesn't much matter how well-thought-out my views may be if the market isn't listening. <br /><br />In the end, if we are going to be successful in the market, we have to know when to abandon our logic and simply go with the flow of the emotions. On the other hand, the markets will eventually shift gears and it is at that point where our logic will be important. <br /><br />So while I am troubled by the seemingly irrational behavior of the market that I'm seeing at this point, I'm going to respect those positive emotions and not fight them. However, I am watching extremely closely for signs that my logic in support of a pullback may actually start to kick in. When the emotions begin to align with my logic, then I know it will be time to press my trades. <br /><br />We have a mixed open on the way as some good earnings from Cisco (CSCO) and Disney (DIS) fail to offset concerns about jumps in oil and commodity prices. Europe is trading up while Asia is mostly down. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: UTSI +20.5%, MFLX +18.3%, KOPN +13.3%, SVR +11.6% (also upgraded to Overweight at Lehman), OPTV +11.6%, ONNN +10.4%, GRS +9.5%, CHRD +7.9%, AOB +7.2%, LMIA +7.2%, GMXR +6.1%, ZGEN +5.2% (also upgraded to Hold at Citigroup), MCHX +4.8%, AFN +4.2%, CRL +4.0%, XCO +4.0%, LXU +3.7%, PACR +3.4%, RIG +3.4%, OSIP +3.2%, WMS +2.8%, DVN +2.2%, DIS +2.0%, FTO +1.8%, TIE +1.6%... Other news: CLWR +13.8% (Clearwire and Sprint close to announcing $12 bln joint venture), SPPI +10.6% (Par Pharmaceutical acquires Spectrum Pharmaceutical's interest in sumatriptan injection), S +7.7% (Clearwire and Sprint close to announcing $12 bln joint venture), EP +3.7% (still checking), MBI +2.8% (issued letter to shareholders), XTO +1.8% (Cramer makes positive comments on MadMoney), MOT +1.5% (Carl Icahn discloses 7.6% stake in amended 13D filing; up from 6.4% last reported on 3/27)... Analyst upgrades: TLCV +23.2% (upgraded to Sector Outperform at CIBC), VDSI +6.0% (upgraded to Buy at Jefferies), MF +5.5% (upgraded to Overweight at Lehman), YRCW +4.7% (upgraded to Overweight at Stephens), CNET +2.4% (initiated with Buy at Kaufman), APC +2.1% (upgraded to Outperform from Market Perform at Bernstein; also Cramer makes positive comments on MadMoney), CMCSA +1.6% (upgraded to Buy at Soleil), RHD +1.6% (upgraded to Hold at Deutsche Bank), SLE +1.3% (upgraded to Market Perform at Wachovia).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: SNCR -46.0% (also downgraded to Market Weight at Weisel and downgraded to Hold at Needham), PRXI -12.2%, ASYT -9.1%, JKHY -9.1%, PRA -8.6%, THQI -6.6%, PNM -6.5% (also downgraded to Underperform at Wachovia), HK -6.4% (also announces $500 million offering of senior notes and announces public offering of 21,000,000 shares of common stock ), UTI -5.7%, CTSH -5.2%, MFB -5.1%, EXP -4.9%, OSUR -4.9%, CELL -4.9%, RFMD -4.3% (also announces strategic restructuring), HAR -4.0%, BIDZ -3.8%, CUTR -3.6%, GSX -3.2%, POL -3.0%, SAM -2.9%, AEG -2.5%, UPL -2.3%, TOT -2.1%, VCLK -2.1%, NILE -2.0%... Select Chinese names trading lower following weakness in overseas trading (Hang Seng closed -2.5%; Shanghai Composite closed -4.1%): SNP -4.0%, LFC -3.7%, ACH -3.7%, CHL -3.1%, CN -1.2%... Other news: PAA -2.4% (announces offering of common units), ITRI -2.1% (announces sale of 3.4 million shares of common stock at $94.47), BZH -2.1% (discloses in 8-k that it received a default notice from The Bank of New York Trust Company National Association), UBS -1.8% (still checking), CEPH -1.7% (announces FDA advisory committee recommendation against approval of an expanded label for FENTORA), BHP -1.5% (still checking)... Analyst downgrades: GGC -10.9% (downgraded to Sell at Citigroup), PTR -5.6% (downgraded to Underweight at JPMorgan), IPHS -4.7% (downgraded to Neutral from Outperform at Credit Suisse), BYD -3.5% (initiated with Sell at BofA), CTRP -3.2% (downgraded to Neutral at Piper), SOHU -2.7% (downgraded to Hold at Deutsche Bank), IAR -2.5% (downgraded to Equal Weight at Lehman), NITE -2.4% (downgraded to Equal Weight at Lehman), FTEK -1.3% (downgraded to Equal Weight at Morgan Stanley), KOF -1.1% (downgraded to Equal Weight at Morgan Stanley).